2023-02-012024-01-312024-01-31false05678151ELITE HEALTH SOLUTIONS LIMITED2024-10-31iso4217:GBPxbrli:pure056781512023-02-01056781512024-01-31056781512023-02-012024-01-31056781512022-02-01056781512023-01-31056781512022-02-012023-01-3105678151bus:SmallEntities2023-02-012024-01-3105678151bus:AuditExempt-NoAccountantsReport2023-02-012024-01-3105678151bus:FullAccounts2023-02-012024-01-3105678151bus:PrivateLimitedCompanyLtd2023-02-012024-01-3105678151core:WithinOneYear2024-01-3105678151core:AfterOneYear2024-01-3105678151core:WithinOneYear2023-01-3105678151core:AfterOneYear2023-01-3105678151core:ShareCapital2024-01-3105678151core:SharePremium2024-01-3105678151core:RevaluationReserve2024-01-3105678151core:OtherReservesSubtotal2024-01-3105678151core:RetainedEarningsAccumulatedLosses2024-01-3105678151core:ShareCapital2023-01-3105678151core:SharePremium2023-01-3105678151core:RevaluationReserve2023-01-3105678151core:OtherReservesSubtotal2023-01-3105678151core:RetainedEarningsAccumulatedLosses2023-01-3105678151core:LandBuildings2024-01-3105678151core:PlantMachinery2024-01-3105678151core:Vehicles2024-01-3105678151core:FurnitureFittings2024-01-3105678151core:OfficeEquipment2024-01-3105678151core:NetGoodwill2024-01-3105678151core:IntangibleAssetsOtherThanGoodwill2024-01-3105678151core:ListedExchangeTraded2024-01-3105678151core:UnlistedNon-exchangeTraded2024-01-3105678151core:LandBuildings2023-01-3105678151core:PlantMachinery2023-01-3105678151core:Vehicles2023-01-3105678151core:FurnitureFittings2023-01-3105678151core:OfficeEquipment2023-01-3105678151core:NetGoodwill2023-01-3105678151core:IntangibleAssetsOtherThanGoodwill2023-01-3105678151core:ListedExchangeTraded2023-01-3105678151core:UnlistedNon-exchangeTraded2023-01-3105678151core:LandBuildings2023-02-012024-01-3105678151core:PlantMachinery2023-02-012024-01-3105678151core:Vehicles2023-02-012024-01-3105678151core:FurnitureFittings2023-02-012024-01-3105678151core:OfficeEquipment2023-02-012024-01-3105678151core:NetGoodwill2023-02-012024-01-3105678151core:IntangibleAssetsOtherThanGoodwill2023-02-012024-01-3105678151core:ListedExchangeTraded2023-02-012024-01-3105678151core:UnlistedNon-exchangeTraded2023-02-012024-01-3105678151core:MoreThanFiveYears2023-02-012024-01-3105678151core:Non-currentFinancialInstruments2024-01-3105678151core:Non-currentFinancialInstruments2023-01-3105678151dpl:CostSales2023-02-012024-01-3105678151dpl:DistributionCosts2023-02-012024-01-3105678151core:LandBuildings2023-02-012024-01-3105678151core:PlantMachinery2023-02-012024-01-3105678151core:Vehicles2023-02-012024-01-3105678151core:FurnitureFittings2023-02-012024-01-3105678151core:OfficeEquipment2023-02-012024-01-3105678151dpl:AdministrativeExpenses2023-02-012024-01-3105678151core:NetGoodwill2023-02-012024-01-3105678151core:IntangibleAssetsOtherThanGoodwill2023-02-012024-01-3105678151dpl:GroupUndertakings2023-02-012024-01-3105678151dpl:ParticipatingInterests2023-02-012024-01-3105678151dpl:GroupUndertakingscore:ListedExchangeTraded2023-02-012024-01-3105678151core:ListedExchangeTraded2023-02-012024-01-3105678151dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-02-012024-01-3105678151core:UnlistedNon-exchangeTraded2023-02-012024-01-3105678151dpl:CostSales2022-02-012023-01-3105678151dpl:DistributionCosts2022-02-012023-01-3105678151core:LandBuildings2022-02-012023-01-3105678151core:PlantMachinery2022-02-012023-01-3105678151core:Vehicles2022-02-012023-01-3105678151core:FurnitureFittings2022-02-012023-01-3105678151core:OfficeEquipment2022-02-012023-01-3105678151dpl:AdministrativeExpenses2022-02-012023-01-3105678151core:NetGoodwill2022-02-012023-01-3105678151core:IntangibleAssetsOtherThanGoodwill2022-02-012023-01-3105678151dpl:GroupUndertakings2022-02-012023-01-3105678151dpl:ParticipatingInterests2022-02-012023-01-3105678151dpl:GroupUndertakingscore:ListedExchangeTraded2022-02-012023-01-3105678151core:ListedExchangeTraded2022-02-012023-01-3105678151dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-02-012023-01-3105678151core:UnlistedNon-exchangeTraded2022-02-012023-01-3105678151core:NetGoodwill2024-01-3105678151core:IntangibleAssetsOtherThanGoodwill2024-01-3105678151core:LandBuildings2024-01-3105678151core:PlantMachinery2024-01-3105678151core:Vehicles2024-01-3105678151core:FurnitureFittings2024-01-3105678151core:OfficeEquipment2024-01-3105678151core:AfterOneYear2024-01-3105678151core:WithinOneYear2024-01-3105678151core:ListedExchangeTraded2024-01-3105678151core:UnlistedNon-exchangeTraded2024-01-3105678151core:ShareCapital2024-01-3105678151core:SharePremium2024-01-3105678151core:RevaluationReserve2024-01-3105678151core:OtherReservesSubtotal2024-01-3105678151core:RetainedEarningsAccumulatedLosses2024-01-3105678151core:NetGoodwill2023-01-3105678151core:IntangibleAssetsOtherThanGoodwill2023-01-3105678151core:LandBuildings2023-01-3105678151core:PlantMachinery2023-01-3105678151core:Vehicles2023-01-3105678151core:FurnitureFittings2023-01-3105678151core:OfficeEquipment2023-01-3105678151core:AfterOneYear2023-01-3105678151core:WithinOneYear2023-01-3105678151core:ListedExchangeTraded2023-01-3105678151core:UnlistedNon-exchangeTraded2023-01-3105678151core:ShareCapital2023-01-3105678151core:SharePremium2023-01-3105678151core:RevaluationReserve2023-01-3105678151core:OtherReservesSubtotal2023-01-3105678151core:RetainedEarningsAccumulatedLosses2023-01-3105678151core:NetGoodwill2022-02-0105678151core:IntangibleAssetsOtherThanGoodwill2022-02-0105678151core:LandBuildings2022-02-0105678151core:PlantMachinery2022-02-0105678151core:Vehicles2022-02-0105678151core:FurnitureFittings2022-02-0105678151core:OfficeEquipment2022-02-0105678151core:AfterOneYear2022-02-0105678151core:WithinOneYear2022-02-0105678151core:ListedExchangeTraded2022-02-0105678151core:UnlistedNon-exchangeTraded2022-02-0105678151core:ShareCapital2022-02-0105678151core:SharePremium2022-02-0105678151core:RevaluationReserve2022-02-0105678151core:OtherReservesSubtotal2022-02-0105678151core:RetainedEarningsAccumulatedLosses2022-02-0105678151core:AfterOneYear2023-02-012024-01-3105678151core:WithinOneYear2023-02-012024-01-3105678151core:Non-currentFinancialInstrumentscore:CostValuation2023-02-012024-01-3105678151core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-012024-01-3105678151core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-012024-01-3105678151core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-012024-01-3105678151core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-012024-01-3105678151core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-012024-01-3105678151core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-012024-01-3105678151core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-012024-01-3105678151core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-012024-01-3105678151core:Non-currentFinancialInstrumentscore:CostValuation2024-01-3105678151core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-3105678151core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-3105678151core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-3105678151core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-3105678151core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-3105678151core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-3105678151core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-3105678151core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-3105678151core:Non-currentFinancialInstrumentscore:CostValuation2023-01-3105678151core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-01-3105678151core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-01-3105678151core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-01-3105678151core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-01-3105678151core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-01-3105678151core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-01-3105678151core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-01-3105678151core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-01-3105678151bus:Director12023-02-012024-01-3105678151bus:Director22023-02-012024-01-3105678151core:FurnitureFittingsToolsEquipment2023-01-3105678151core:FurnitureFittingsToolsEquipment2024-01-3105678151core:FurnitureFittingsToolsEquipment2023-02-012024-01-31

ELITE HEALTH SOLUTIONS LIMITED

Registered Number
05678151
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2024

ELITE HEALTH SOLUTIONS LIMITED
Company Information
for the year from 1 February 2023 to 31 January 2024

Directors

O'KELLY, Noel Ignatius, Dr
SMITH, Judith

Company Secretary

SMITH, Judith

Registered Address

The Yews School Lane
West Ashby
Horncastle
LN9 5PY

Registered Number

05678151 (England and Wales)
ELITE HEALTH SOLUTIONS LIMITED
Balance Sheet as at
31 January 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets3320,553325,109
320,553325,109
Current assets
Cash at bank and on hand8,02618,276
8,02618,276
Creditors amounts falling due within one year4(75,657)(109,467)
Net current assets (liabilities)(67,631)(91,191)
Total assets less current liabilities252,922233,918
Creditors amounts falling due after one year5(24,888)(33,245)
Net assets228,034200,673
Capital and reserves
Called up share capital22
Profit and loss account228,032200,671
Shareholders' funds228,034200,673
The financial statements were approved and authorised for issue by the Board of Directors on 31 October 2024, and are signed on its behalf by:
SMITH, Judith
Director
Registered Company No. 05678151
ELITE HEALTH SOLUTIONS LIMITED
Notes to the Financial Statements
for the year ended 31 January 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:
2.Average number of employees

20242023
Average number of employees during the year00
3.Tangible fixed assets

Land & buildings

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 01 February 23197,335143,573599341,507
At 31 January 24197,335143,573599341,507
Depreciation and impairment
At 01 February 23-16,392616,398
Charge for year-4,4081484,556
At 31 January 24-20,80015420,954
Net book value
At 31 January 24197,335122,773445320,553
At 31 January 23197,335127,181593325,109
4.Creditors: amounts due within one year

2024

2023

££
Taxation and social security7,48717,497
Other creditors67,27191,070
Accrued liabilities and deferred income899900
Total75,657109,467
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
5.Creditors: amounts due after one year

2024

2023

££
Other creditors24,88833,245
Total24,88833,245